Anthropic's IPO roadshow slips to mid-October as it finalizes a $15 billion credit facility

Anthropic's initial public offering has slipped. The prospectus is now expected in late September with the marketing roadshow launching mid-October at the earliest, according to reporting from Reuters, and the company is still aiming to list before the November 2026 midterm elections. The delay tracks the company's work on financing rather than any disclosed problem with the offering itself.

The financing piece is substantial. Anthropic is finalizing a revolving credit facility of roughly $15 billion, led by Morgan Stanley with Goldman Sachs, JPMorgan and Citigroup participating. That is six times the $2.5 billion line it carried in 2025 and well above the $10 billion the company originally targeted. Locking a revolver before assigning underwriting roles is conventional pre-IPO sequencing rather than a regulatory requirement, so the size is the signal here, not the timing. Separately, AMD has committed to a strategic equity investment of up to $5 billion tied to deploying as much as 2 gigawatts of Instinct MI450 GPUs; that money is contingent and payable through fiscal 2028, so it is a pledge against future milestones rather than cash already on the balance sheet.

The valuation is where the case gets contestable. Investors are reported to be targeting $2 trillion or more, against a $965 billion post-money valuation set only months earlier, which would make this the largest listing on record and exceed the $1.77 trillion SpaceX priced at. The arithmetic behind that number leans on annualized revenue reaching $100 billion to $120 billion by the end of 2026, up from $47 billion in May, and implies something closer to $190 billion to $200 billion by 2028. Neither the timetable nor the valuation is settled.

Governance is the second open question, and it is structural rather than cosmetic. The Long-Term Benefit Trust holds no equity, seats three trustees including Ben Bernanke, Neil Buddy Shah and Richard Fontaine, carries escalating board-election rights, and can only be removed on an 85% shareholder vote, while founders retain super-voting shares . Public-market buyers would therefore be purchasing economic exposure without board control, an arrangement that has not been tested at this scale. Watch for the prospectus filing itself, the final facility terms and the underwriting syndicate, all of which will say more about the real valuation range than the headline target does.

Related Stocks

• AMD